Cellomatics Quarterly Newsletter (Winter, 2023)
Our guiding principle is Our Expertise, Your Discovery. It’s what drives us here at Cellomatics.
"Welcome to our?Winter?newsletter.??
This quarter has been busy for us as we have spent the last few months attending (and winning!) several awards, networking at industry events and showcasing our offering and expertise to prospective clients.
We continue to update our website, ensuring that our data sets are as current and accurate as possible. Our latest page to be completed is our Respiratory page, which now features an interactive illustration as well as up-to-date data sets on the services we offer at Cellomatics.
We are proud to support the important work of our clients, so if you think we can help you,?please get in touch. On behalf of the team at Cellomatics?I would like to wish you the best during this festive period and hope you have a happy and healthy 2024”?
What our clients say
Over the years we have worked with many impactful businesses and have built long-standing relationships with our clients, resulting in some excellent feedback.
Indranil Mukhopadhyay, Assistant Vice President, Enveda Biosciences,?said:
“I have been working with Cellomatics for over 4 years in multiple projects in the areas of inflammation and oncology. Some of the projects were customised to suit our needs. The scientific team at Cellomatics were very efficient and proactive in helping us setting up the experiments. The project management team at Cellomatics has been doing a fantastic job by providing timely updates and regular communication. It has been an absolute pleasure working with Cellomatics and we look forward to more productive and fruitful collaboration in future.”
Recent highlights
It has been another successful quarter for us at Cellomatics, and we have been putting our black tie outfits to good use by attending multiple award ceremonies over the last few months. We were thrilled to be crowned as winners of the Pharma Industry Award for Pharma Contract Services Company of the Year, the Signature Award for Small Business of the Year and the Business Master’s Award for the International Trade category. It is an honour to be recognised for our achievements both in the life sciences sector and as a business.
We are now looking forward to expanding our trophy cabinet further in 2024!
A focus on: Inflammation
Our team have focused on showcasing our Inflammation expertise with the creation of?an?Inflammation Hub where you can view a selection of downloadable technical notes highlighting our assays, data sets and offering.?
At Cellomatics, we are a preclinical Inflammation CRO providing physiologically relevant in vitro inflammatory disease models to investigate the efficacy and/or toxicity of drug molecules. These assays can be customised and designed to suit client’s requirements with multiple end-point measurements.
We offer a range of Inflammation CRO services?as shown below.
For our free Inflammation?pdf download, click here.
Find out more here.
Keeping in touch
If we can assist you in providing validated clinically relevant?in vitro?disease models or bespoke??in?vitro?models using cell-based approaches to support the progression of your assets to the next stage of drug development, then please?get in touch.??